KELOWNA, BRITISH COLUMBIA--(MARKET WIRE)--Jun 26, 2006 -- To facilitate the progress of its diabetes product development project, Pheromone Sciences Corp. (“Pheromone”) (TSX VENTURE:PHS.V - News) is pleased to announce that Mr. Justin Leushner of London, Ontario, has been named President of the Company, effective immediately. In addition, Mr. Leushner has been appointed to the Board of Directors. He is currently the manager of the Islet Transplant Program at the London Health Sciences Centre’s (“LHSC”) world renowned Multi-Organ Transplant Program. His role as President will include primary responsibility for monitoring the progress of Pheromone’s diabetes research project being conducted at the LHSC’s facilities. The project is Pheromone’s primary research focus and is being funded by the Company’s recently completed $3.2 million financing.
